ASPET

This study reveals an elevation of CYP2E1 autoantibodies in rheumatoid arthritis patients and efficacy of a CYP2E1 inhibitor to lessen symptoms in rheumatoid arthritis animal models, indicating the role for CYP2E1 in autoimmune conditions. Read our Editor's Choice: https://ow.ly/P6Qv50Zjo8R

Make sure your research is included in this special collection highlighting innovative frameworks that move beyond static models toward dynamic, systems-level modulation of signaling networks, and enable the rational design of effective and safe therapeutics for complex neurodegenerative disorders. Learn more and submit your work: https://ow.ly/tEBB50ZjnQi